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eceptor-regulated class I phosphoinositide 3-kinases
(PI3K) phosphorylate the membrane lipid phos-
phatidylinositol (PtdIns)-4,5-P
 
2
 
 to PtdIns-3,4,5-P
 
3
 
.
This, in turn, recruits and activates cytosolic effectors with
 
PtdIns-3,4,5-P
 
3
 
–binding pleckstrin homology (PH) domains,
thereby controlling important cellular functions such as
proliferation, survival, or chemotaxis. The class I
 
B
 
 p110
 
 
 
/p101
PI3K
 
 
 
 is activated by G
 
  
 
 on stimulation of G protein–
coupled receptors. It is currently unknown whether in living
 
cells G
 
  
 
 acts as a membrane anchor or an allosteric
activator of PI3K
 
 
 
, and which role its noncatalytic p101
subunit plays in its activation by G
 
  
 
. Using GFP-tagged
PI3K
 
 
 
 subunits expressed in HEK cells, we show that G
 
  
R
 
recruits the enzyme from the cytosol to the membrane by
interaction with its p101 subunit. Accordingly, p101 was
found to be required for G protein–mediated activation of
PI3K
 
 
 
 in living cells, as assessed by use of GFP-tagged
PtdIns-3,4,5-P
 
3
 
–binding PH domains. Furthermore, mem-
brane-targeted p110
 
 
 
 displayed basal enzymatic activity,
but was further stimulated by G
 
  
 
, even in the absence of
p101. Therefore, we conclude that in vivo, G
 
  
 
 activates
PI3K
 
 
 
 by a mechanism assigning speciﬁc roles for both
PI3K
 
 
 
 subunits, i.e., membrane recruitment is mediated via
the noncatalytic p101 subunit, and direct stimulation of
G
 
  
 
 with p110
 
 
 
 contributes to activation of PI3K
 
 
 
.
 
Introduction
 
Phosphoinositide 3-kinases (PI3Ks)* phosphorylate the D3
position of the inositol ring of phosphoinositides, thereby
generating intracellular signaling molecules (Stephens et al.,
1993; Fruman et al., 1998). These phospholipids, i.e., phos-
phatidylinositol (PtdIns)-3-P, PtdIns-3,4-P
 
2
 
, and PtdIns-
3,4,5-P
 
3
 
, have been implicated in cellular functions including
chemotaxis, differentiation, glucose homeostasis, proliferation,
survival, and trafficking (Vanhaesebroeck et al., 2001; Cantley,
2002). They transmit signals by recruiting effector molecules
that possess specific lipid-binding domains. FYVE domains
and PX domains bind to PtdIns-3-P with high affinity, whereas
a subgroup of pleckstrin homology (PH) domains, containing
a highly basic motif, preferentially binds PtdIns-3,4-P
 
2
 
 and
PtdIns-3,4,5-P
 
3
 
 (Hurley and Misra, 2000; Simonsen et al.,
2001; Wishart et al., 2001).
PtdIns-3,4,5-P
 
3
 
 represents the major product of class I
PI3Ks in vivo. These lipid kinases are under tight control of
cell surface receptors, including receptor tyrosine kinases
(RTK) or G protein–coupled receptors (GPCR; Katso et al.,
2001). All class I members are heterodimers consisting of a
p110 catalytic and a p85- or p101-type noncatalytic subunit.
The class I
 
A
 
 p110 isoforms 
 
 
 
, 
 
 
 
, and 
 
 
 
 form a complex with
p85 adaptor subunits, whereas the only class I
 
B
 
 member
(p110
 
 
 
) is associated with a p101 noncatalytic subunit. The
p85 subunit binds to tyrosine-phosphorylated RTKs. This
interaction has two consequences resulting in activation of
the PI3K. First, the cytosolic enzyme translocates to the inner
leaflet of the plasma membrane, giving p110 access to its
lipid substrate (Gillham et al., 1999). Second, the interaction
with the tyrosine-phosphorylated receptor induces a confor-
mational change of p85 that results in disinhibition of p110
enzymatic activity (Yu et al., 1998). Because the p85 regulatory
subunit inhibits the p110 catalytic subunit, it is feasible that
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constitutively membrane-associated class I
 
A
 
 p110 mutants
trigger downstream responses characteristic of growth factor
action (Klippel et al., 1996).
Similar to class I
 
A
 
 PI3Ks, unstimulated PI3K
 
 
 
 is predomi-
nantly localized in the cytosol, whereas GPCRs induced an in-
crease of PI3K
 
 
 
 in the membrane fraction (Al-Aoukaty et al.,
1999; Naccache et al., 2000). GPCRs activate PI3K
 
 
 
 through
direct interaction with G
 
  
 
, whereas a stimulation by G
 
 
 
 is
quantitatively less important (Stoyanov et al., 1995; Stephens
et al., 1997; Leopoldt et al., 1998). However, little is known
about the activating mechanism, e.g., it remains elusive
whether G
 
  
 
 functions as a membrane anchor or an allosteric
regulator of PI3K
 
 
 
. Although the p101 subunit has been pro-
posed to act as an indispensable adaptor linking G
 
  
 
 with
p110
 
 
 
 (Stephens et al., 1997), in vitro studies have suggested
that p101 is not mandatory for G
 
  
 
-induced stimulation of
PI3K
 
 
 
 (Stoyanov et al., 1995). Moreover, a direct interaction
of G
 
  
 
 with NH
 
2
 
- and COOH-terminal regions of p110
 
 
 
 has
been demonstrated (Leopoldt et al., 1998). Further support for
a direct interaction of G
 
  
 
 with the p110 catalytic subunit
came from the observation that the p110
 
 
 
 isoform can also be
stimulated by G
 
  
 
, regardless of whether p85 is present or not
(Kurosu et al., 1997; Maier et al., 1999, 2000). Nevertheless,
the noncatalytic p101 subunit of PI3K
 
 
 
 binds tightly to G
 
  
 
,
suggesting specific roles in G protein–induced regulation of this
lipid kinase. For instance, in vitro studies showed that G
 
  
 
-
stimulated p110
 
 
 
 potently produced PtdIns-3-P, whereas the
G
 
  
 
-activated heterodimeric p110
 
 
 
/p101 counterpart po-
tently catalyzed the formation of PtdIns-3,4,5-P
 
3
 
 (Maier et al.,
1999). This suggests that p101 may affect the interaction of
G
 
  
 
-stimulated p110
 
 
 
 with the lipid interface.
Therefore, the exact roles of G
 
  
 
 and PI3K
 
 
 
 subunits in G
protein–induced activation of PI3K
 
 
 
 in living cells remain
unclear. Hence, we asked whether G
 
  
 
 functions as a mem-
brane anchor and/or allosteric activator, and whether p101 is
required for proper function of p110
 
 
 
 in vivo. To tackle these
questions, we examined cellular events leading to activation of
PI3K
 
 
 
 using fluorescent fusion proteins in living cells.
 
Results
 
Characterization of fluorescent PI3K fusion proteins
 
To visualize PI3K
 
 
 
 subunits in vivo, we generated con-
structs encoding p110
 
 
 
 and p101 fused to YFP or CFP (Fig.
1 A). Their expression in human embryonic kidney (HEK)
293 cells was verified by immunoblot analysis using an anti-
body against GFP (Fig. 1 B). The catalytic activity and G
 
  
 
sensitivity of PI3K
 
 
 
 fusion proteins was confirmed by in
vitro lipid kinase assays after immunoprecipitation with an
mAb recognizing only intact p110
 
 
 
 (Fig. 1 C). Precipitates
from vector-transfected control cells neither exhibited
p110
 
 
 
 immunoreactivity nor lipid kinase activity. These re-
sults demonstrate that YFP-fused p110
 
 
 
 or p101 retain es-
sential functions of the wild-type PI3K
 
 
 
.
 
Subcellular distribution of PI3K
 
 
 
 subunits 
and instability of monomeric p101
 
Next, we examined the subcellular distribution of the YFP-
tagged PI3K
 
 
 
 subunits in living cells by confocal laser scan-
ning microscopy. Although YFP was uniformly distributed
inside HEK cells (unpublished data), fluorescence signals
from YFP fused to the NH
 
2 
 
or COOH termini of p110
 
 
 
were only detected in the cytosolic compartment (Fig. 2 A,
top). However, a small fraction of the YFP-fused p110
 
 
 
 was
also detected in the nucleus when coexpressed with wild-
type p101 (Fig. 2 B, top). The same distribution was seen
for YFP-tagged p101 coexpressed with wild-type p110
 
 
 
(Fig. 2 B, bottom). Thus, fluorescent PI3K
 
 
 
 subunits form
heterodimers (see next section), present in the cytosol and
nucleus of HEK cells, whereas distribution of the p110
 
 
 
subunit alone seems restricted to the cytosol. Interestingly,
YFP-fused p101 alone showed a predominant nuclear local-
Figure 1. Construction and characterization of fluorescent PI3K  
fusion proteins. (A) Schematic representation of the wild-type, 
fluorescent, and membrane-targeted PI3K  subunits. A YFP (or CFP) 
tag was fused to either the NH2- or the COOH terminus of p110  
and p101. The p110 -CAAX fusion protein contains an isoprenylation 
motif (bars for lipid modifications). (B) Differently fluorescence-
tagged PI3K  subunits were coexpressed in HEK cells, and cell 
lysates were subjected to SDS-PAGE followed by immunoblotting 
with a GFP-specific antibody. (C) Catalytic activity of fluorescent 
PI3K  fusion proteins. HEK cells were transfected with the indicated 
plasmids. Lysates were subjected to immunoprecipitation (IP) with 
( ) or without ( ) an anti-p110  antibody. immunoprecipitation 
was controlled by immunoblotting (IB) with another anti-p110  
antibody. Shown are chemiluminescence images (top panels). 
Immunoprecipitates were assayed for in vitro PI3K activity in 
the absence or presence of 120 nM G   using PtdIns-4,5-P2–
containing lipid vesicles and  [
32P]ATP as substrates. Depicted are 
autoradiographs of the generated 
32P-PtdIns-3,4,5-P3 (bottom panels).T
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ization with a significantly lower overall fluorescence inten-
sity (Fig. 2 A, bottom).
To explore the possibility that expression levels of p101
could depend on the coexpression of p110 , we transfected
HEK cells with different ratios of plasmids encoding fluo-
rescent p110  or p101 and analyzed total cell lysates by im-
munoblotting using an anti-GFP antibody (Fig. 2 C). The
expression level of p110  correlated with the amount of the
p110  (but not the p101) plasmid. In contrast, the expres-
sion level of p101 was also dependent on the amount of the
p110  plasmid. Hence, the stability of p101 depends on the
coexpression of p110 , but not vice versa. The poor cytoso-
lic fluorescence of YFP-tagged p101 in the absence of
p110  may thus be explained by cytosolic degradation of
monomeric p101.
In vivo dimerization of PI3K  subunits
To directly demonstrate heterodimerization of PI3K  sub-
units in living cells, we used fluorescence resonance energy
transfer (FRET). FRET between two fluorophores, e.g.,
CFP and YFP, is restricted to distances of  100 Å, and
therefore, provides direct evidence for a protein–protein in-
teraction (Teruel and Meyer, 2000). We coexpressed CFP-
and YFP-tagged PI3K  subunits and determined FRET by
following the donor (CFP) recovery during acceptor (YFP)
bleach (Fig. 3 A). All combinations showed significant
FRET, although quantitative differences were evident.
Because FRET efficiency is a function of the distance be-
tween two fluorophores, quantitative differences may repre-
sent different distances of the fluorescent tags fused to the
NH2 or COOH termini of p101 and p110  in a particular
combination. However, the different FRET efficiencies may
Figure 2. Expression and subcellular distribution of fluorescent 
p110  and p101 in HEK cells. (A) Cells were transfected with plasmids 
for YFP-tagged single PI3K  subunits as indicated. Images were 
taken by confocal laser scanning microscopy. Images of typical 
cells are shown. White bars indicate a 10- m scale. (B) Cells were 
cotransfected with both p110  and p101. Only one subunit was 
fused to YFP as indicated. (C) Cells were transfected with plasmids 
encoding fluorescent p110  and p101 at different ratios. The total 
amount of transfected cDNA was kept constant by the addition of 
pcDNA3. Equal amounts of whole-cell lysates were subjected to 
SDS-PAGE followed by immunoblotting with an anti-GFP antibody.
Figure 3. Dimerization of p110  and p101. (A) HEK cells were 
cotransfected with plasmids encoding NH2- or COOH-terminally 
YFP-tagged p110  and NH2- or COOH-terminally CFP-tagged p101 
in different combinations. FRET was measured in vivo. An increase 
in CFP (donor) fluorescence during YFP (acceptor) bleach indicates 
FRET between fluorescent PI3K  subunits. The depicted data represent 
means   SEM of at least 18 single cells in three independent 
transfection experiments. (B) HEK cells were transfected with the 
indicated plasmids. Cytosols were prepared and subjected to gel 
filtration. The elution profiles were analyzed by immunoblotting 
with an anti-GFP antibody (L, load diluted 1:5; V, void volume; 
20–26, fraction numbers).T
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also reflect different degrees of heterodimerization. To ex-
clude the latter, we analyzed heterodimerization of different
p101/p110  combinations by size-exclusion chromatogra-
phy (Fig. 3 B). The elution profile of YFP-p110  (Fig. 3 B,
bottom) was completely shifted to earlier fractions on coex-
pression with CFP-p101 (Fig. 3 B, top), indicating a high
degree of heterodimerization. A similar elution profile was
found for p110 -YFP   CFP-p101 (Fig. 3 B, middle), al-
beit a lower FRET efficiency was detected for this combina-
tion. Hence, the different FRET efficiencies observed are
not due to different degrees of dimerization, but likely re-
flect different distances of the fluorescent tags in the p101/
p110  heterodimer. Thus, their two NH2 termini as well as
their two COOH termini are in close proximity, whereas
the NH2 terminus of each subunit is relatively far from the
COOH terminus of the other.
G   dimers recruit PI3K  to membranes 
via the p101 subunit
Current concepts of PI3K activation are based on the re-
cruitment of the cytosolic lipid kinase to the plasma mem-
brane (Klippel et al., 1996). In the case of PI3K , the
major stimulus is assumed to be G  , which is membrane-
bound and has been shown to directly bind to both kinase
subunits under in vitro conditions (Stephens et al., 1997;
Maier et al., 1999). Therefore, we asked whether overex-
pression of free G   directs YFP-fused PI3K  subunits to
the cell membrane in vivo. Surprisingly, p110  was not
membrane-localized in the presence of coexpressed G   in
HEK cells (Fig. 4 A, top). In contrast, G   recruited p101
to the membrane, resulting in accumulation of NH2- or
COOH-terminally YFP-tagged p101 at both plasma- and
endomembranes (Fig. 4 A, bottom, and Fig. 4 B). This cor-
responds to the subcellular distribution of overexpressed
G   dimers (see below), suggesting that p101 interacted
with membrane-bound G  .
Next, we examined the subcellular localization of p110 /
p101 heterodimers in the presence of free G  . When coex-
pressed with p101 and G  , the p110  fluorescent signal
was at, or close to, plasma and endosomal membranes of
HEK cells (Fig. 4 C, top). The same picture emerged when
the YFP-tag was fused to p101 (unpublished data). Corre-
spondingly, CFP-tagged G 1 coexpressed with G 2 exhib-
ited a similar subcellular distribution like fluorescent het-
erodimeric PI3K  (compare Figs. 4 C and 4 D), and
immunoblotting of membrane-derived proteins confirmed
an enrichment of PI3K  in the membrane compartment af-
ter overexpression of G   (Fig. 4 E). Together, these data
imply that G   directs cytosolic PI3K  to the membrane
via interaction with p101.
Interestingly, coexpression of heterodimeric PI3K  to-
gether with G   produced a rounded morphology and de-
Figure 4. Membrane recruitment of PI3K  by 
G  . The effect of coexpression of G   on the 
subcellular distribution of p110 , p101, and 
heterodimeric PI3K  in HEK cells was analyzed 
by confocal laser scanning microscopy. Images of 
typical cells are shown (white bars, 10  m). 
(A) Coexpression of monomeric PI3K  subunits 
with G  . (B) Controls; coexpression of YFP-p101 
with G 1, G 2, G 1 2, or G 1 2 and the G  -
scavenging G i2. (C) Coexpression of heterodimeric 
PI3K  with G  . Note the round shape of the cells. 
Controls; coexpression of G   with YFP or with 
kinase-deficient YFP-p110 -K833R and p101; 
effect of 100 nM wortmannin. (D) Subcellular 
localization of G  . Cells were transfected with a 
plasmid encoding CFP-tagged G 1 alone or together 
with the G 2 plasmid. (E) Immunoblot analysis of 
membrane fractions. HEK cells were transfected 
with the plasmids encoding PI3K , G  , or both 
together. To avoid rounding and detachment of the 
cells, the kinase-deficient mutant YFP-p110 -K833R 
was used. Membrane fractions were prepared and 
analyzed by immunoblotting with anti-p110  and 
anti-G  antibodies.T
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tachment of the cells (Fig. 4 C). This morphological change
was reversed by treatment with 100 nM of the PI3K inhibi-
tor wortmannin in approximately half of the cells within 30
min, and not seen when a kinase-deficient YFP-p110 -
K833R mutant was used (Fig. 4 C). Hence, the morpholog-
ical change was related to the enzymatic activity of PI3K 
stimulated by the coexpressed G  .
p101 is required for G protein–mediated activation 
of p110  in vivo
Because changes in morphology are not a very reliable mea-
sure of PI3K activity, we examined phosphorylation of en-
dogenous protein kinase B (PKB or Akt) as an established
PI3K-specific read-out system. To avoid detachment of the
cells as a consequence of constitutive PI3K  stimulation by
overexpressed G  , we transiently stimulated the heterolo-
gously expressed Gi-coupled formyl-methionyl-leucyl-phenyl-
alanine (fMLP) receptor, which is known to activate PI3K 
(Stephens et al., 1993). Stimulation with fMLP induced Akt
phosphorylation in HEK cells in the same range as with FCS
(Fig. 5 A). However, Akt phosphorylation was only seen
when the receptor was coexpressed with both PI3K  sub-
units, and not with p110  alone. These data imply that p101
is required for GPCR-induced activation of PI3K  in vivo.
To measure PI3K  activity by a complementary experi-
mental approach, the effects of fMLP receptor stimulation
on the subcellular distribution of GFP-GRP1PH fusion pro-
teins were examined. Recruitment of the GFP-labeled PH
domain of general receptor for phosphoinositides-1 (GRP1),
a PI3K-activated exchange factor for ADP-ribosylation fac-
tors (Lietzke et al., 2000), has been applied to detect forma-
tion of PtdIns-3,4,5-P3 with high affinity and selectivity
(Gray et al., 1999; Balla et al., 2000). fMLP stimulation had
no effect on the subcellular distribution of GFP-GRP1PH in
HEK cells expressing either the receptor or PI3K  alone
(Fig. 5 B, top two panels), whereas subsequent stimulation
with EGF induced a rapid membrane recruitment of the Ptd-
Ins-3,4,5-P3 sensor, presumably through activation of an en-
dogenously expressed RTK-sensitive class IA PI3K. In cells
coexpressing the fMLP receptor and heterodimeric PI3K ,
fMLP stimulation induced a rapid membrane translocation
of GFP-GRP1PH (Fig. 5 B, third panel), indicating that this
effect indeed reflects fMLP receptor–mediated stimulation
of PI3K . Accordingly, the fMLP-induced effect was sensi-
tive to pretreatment with pertussis toxin (PTX; unpublished
data). Interestingly, a slight basal membrane localization of
GFP-GRP1PH was visible in the cells coexpressing het-
erodimeric PI3K  and the fMLP receptor even in the ab-
sence of agonist (Fig. 5 B, third panel). Because this was not
seen after PTX treatment (unpublished data) or in cells
omitting the receptor (Fig. 5 B, second panel), it most likely
reflected a constitutively active fMLP receptor.
Translocation of an isolated PH domain in single cells
may be a more sensitive read-out for PtdIns-3,4,5-P3 pro-
duction than the Akt phosphorylation assay. Hence, we used
Figure 5. Activation of PI3K  by a G protein–coupled receptor. 
(A) Akt phosphorylation. Whole-cell lysates were analyzed by 
immunoblotting using an antibody that specifically recognizes the 
phosphorylated form of Akt. Equal loading was shown by using an 
anti-ERK antibody. Left; FCS-induced Akt phosphorylation in 
untransfected HEK cells. Right; fMLP-induced Akt phosphorylation 
in cells expressing the fMLP receptor and only the catalytic 
(p110 ) or both PI3K  subunits. (B) Membrane recruitment of the 
PtdIns-3,4,5-P3–binding PH domain of GRP1. HEK 293 cells were 
transfected with plasmids encoding the PH domain of GRP1 fused 
to GFP (GFP-GRP1PH), and the human fMLP receptor (fMLP-R), 
p110 , and p101 in different combinations. The localization of 
the GFP-GRP1PH was monitored before and after the addition of 1 
 M fMLP and 100 ng/ml EGF (added 8 min later) by confocal laser 
scanning microscopy. Pictures were taken 4 min after addition of 
either agonist. Images of typical experiments are shown (white 
bars, 10  m). (C) Membrane recruitment of the PtdIns-3,4,5-P3–
binding PH domain of Btk. Instead of GFP-GRP1PH, the PH domain 
of Btk fused to CFP (BtkPH-CFP) was used as a PtdIns-3,4,5-P3 sensor.T
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the GFP-GRP1PH translocation approach to reexamine the
requirement of p101 for receptor-induced PI3K  activation
(Fig. 5 A). Nevertheless, an fMLP-induced membrane re-
cruitment of GFP-GRP1PH in cells coexpressing the receptor
and p110  (but not p101) was not visible (Fig. 5 B, fourth
panel). This finding confirms that the noncatalytic p101
subunit is required for GPCR-mediated stimulation of
PI3K  in living cells.
To further strengthen the findings, we replaced GFP-
GRP1PH by the GFP-fused PH domain of Bruton’s tyrosine
kinase (BtkPH), which has also been described to bind Ptd-
Ins-3,4,5-P3 with high specificity and affinity (Várnai et al.,
1999). As expected, fluorescent BtkPH was distributed
equally between cytosol and nucleus in HEK cells (Fig. 5 C).
However, cells coexpressing the receptor and both PI3K 
subunits exhibited a slight basal membrane localization of
BtkPH-CFP followed by a prominent translocation from the
cytosol to the membrane on exposure to fMLP. Similar to
GFP-GRP1PH, no fMLP-induced redistribution of BtkPH-
CFP was seen in the absence of p101.
Activation of a membrane-targeted 
p110 -CAAX in vivo
The presented data suggest that in living cells, p101 is an in-
dispensable adaptor for GPCR-induced translocation and ac-
tivation of class IB PI3K , which is equivalent to the role of
p85 in RTK-induced class IA PI3K activation. Vice versa,
G   behaves as a membrane anchor recruiting PI3K 
through association with p101. So far, these experiments did
not clarify whether membrane recruitment itself is sufficient
for activation of the enzyme or whether additional allosteric
stimulation is required. To tackle this question, we generated
p110  mutants containing a COOH-terminal isoprenylation
signal, i.e., a CAAX-box motif, which constitutively localizes
p110  to the plasma membrane. p110 -CAAX accumulated
at the plasma membrane of HEK cells, and was able to com-
plex with p101 (Fig. 6, top). Coexpression of G   together
with YFP-p110 -CAAX increased not only fluorescent stain-
ing of endomembranes, but also produced a wortmannin-sen-
sitive rounding of the cells (Fig. 6, bottom) even in the ab-
sence of p101 (not depicted), which was similar to the effect
after coexpression of G   with p110 /p101 dimers (see Fig.
4 C). These observations imply that membrane-bound PI3K 
is not fully active, but can be further activated by G  .
To substantiate this assumption, we analyzed the subcellu-
lar redistribution of GFP-GRP1PH in HEK cells coexpressing
membrane-targeted p110 -CAAX, p101 and the fMLP re-
ceptor in various combinations (Fig. 7 A). A slight basal
membrane localization of the fluorescent PH domain was ev-
ident on coexpression with p110 -CAAX (Fig. 7 A, top
panel) indicating an elevated PtdIns-3,4,5-P3 level. The same
picture emerged when p101 was present in the panel of trans-
fected plasmids (Fig. 7 A, second panel). On coexpression of
the receptor, fMLP induced a significant additional translo-
cation of GFP-GRP1PH from the cytosol to the membrane
(Fig. 7 A, third and fourth panel) indicating additional stim-
ulation of the membrane-bound lipid kinase. Interestingly,
the effect was similar irrespective of whether p101 was
present or not, suggesting direct activation of monomeric
p110 . PTX sensitivity confirmed that fMLP-induced activa-
tion of p110 -CAAX was mediated by Gi proteins (unpub-
lished data). Because G   can activate Ras, which in turn
may activate p110 , one may imagine that fMLP-induced,
p101-independent stimulation of p110 -CAAX was medi-
ated by Ras. However, coexpression of dominant-negative
Ras N17 had no effect on fMLP-induced p110 -CAAX
stimulation, whereas its inhibitory effect was evident when
EGF-induced MAP kinase activation was assessed (Fig. 7 A,
bottom panel). In addition, an indirect autocrine stimulatory
effect was excluded because supernatants of fMLP-stimulated
cells failed to induce GFP-GRP1PH translocation in cells
omitting fMLP receptors (unpublished data).
By using BtkPH-CFP instead of GFP-GRP1PH as the Ptd-
Ins-3,4,5-P3 sensor, we confirmed both the basal enzymatic
activity and fMLP-induced stimulation of membrane-tar-
geted p110 -CAAX, regardless of coexpressed p101 (Fig. 7
B). Furthermore, the Akt phosphorylation assay corrobo-
rated that p101 was dispensable for GPCR-induced stimula-
tion of membrane-targeted p110 -CAAX (Fig. 7 C).
Next, we sought to confirm our principal findings using
nontransformed cells in primary culture with a higher degree
of differentiation than HEK cells. Vascular smooth muscle
(VSM) cells were injected with plasmids encoding the fMLP
receptor, p101, p110  or p110 -CAAX, and GFP-GRP1PH
in different combinations, and redistribution of the fluores-
cent PtdIns-3,4,5-P3 sensor was monitored (Fig. 8). Again,
this series of experiments confirmed that p101 is required
for GPCR-mediated activation of PI3K  in living cells,
whereas membrane-targeted p110  can be stimulated even
in the absence of p101.
Discussion
PI3K  is a key player in the regulation of leukocyte func-
tions such as chemotaxis and superoxide production (Katso
Figure 6. Characterization of a constitutively membrane-associated 
p110 -CAAX. HEK cells were transfected with the indicated plasmids 
and analyzed by confocal laser scanning microscopy. Images of 
typical cells are shown. White bars indicate a 10- m scale. Top 
panel; Subcellular localization of YFP-p110 -CAAX (left) or 
YFP-p101 expressed together with p110 -CAAX (right). Bottom 
panel; Coexpression with G  .T
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et al., 2001). To elucidate the mechanism of how G   acti-
vates the enzyme in vivo, we studied the subcellular localiza-
tion and translocation of GFP-tagged PI3K  subunits and
PH domains in living cells.
A p110 -GFP construct has been previously reported
(Metjian et al., 1999), but data describing a functional in-
teraction of the fusion protein with G proteins are not
available. Therefore, we systematically tagged each PI3K 
subunit and found heterodimerization, enzymatic activity,
and G  -sensitivity of the fusion proteins unaffected by
the tags, whereas a GFP-tagged G  complexed to G  did
not interact with PI3K  (unpublished data). In resting
cells, fluorescent PI3K  was predominantly detected in the
cytosol. This resembles the native situation in which the
vast majority of the endogenous PI3K  pool has been as-
signed to the cytosol (Stephens et al., 1994, 1997; Tang
and Downes, 1997). Thus, the GFP-tagged proteins are ap-
propriate tools to study the cellular events leading to activa-
tion of PI3K .
Recent analysis of p110  crystals gave insights into the
three-dimensional structure of the catalytic PI3K  subunit
(Walker et al., 1999; Pacold et al., 2000). However, the
structure of p101 and the molecular determinants for the in-
teraction of both PI3K  subunits are currently unknown. In
vitro data derived from p101 and p110  deletion mutants
suggest that large areas of p101 may interact with the NH2-
Figure 7. Activation of a constitutively membrane-associated p110 -CAAX. (A) GFP-GRP1PH translocation. HEK cells were transfected with 
plasmids for GFP-GRP1PH and p110 -CAAX, p101, fMLP-R, and dominant-negative Ras N17 in different combinations. Translocation of the 
PtdIns-3,4,5-P3–binding GFP-GRP1PH in response to agonist stimulation was monitored as described above (see Fig. 5). White bars indicate a 
10- m scale. As a positive control for H-Ras N17, cells were transfected with the H-Ras N17 plasmid (same amount as for the GFP-GRP1PH 
translocation experiment) or empty vector. Cells were stimulated with 10 ng/ml EGF, and whole-cell lysates were analyzed by immunoblotting 
with an antibody that specifically recognizes the phosphorylated form of ERK (p-ERK). Equal loading was shown using the anti-ERK-antibody. 
(B) BtkPH-CFP translocation. (C) Akt phosphorylation. The experiment shown in Fig. 5 was repeated. In addition, cells were transfected with 
the plasmid for the membrane-targeted p110 -CAAX instead of wild-type p110 .T
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terminal side of p110  (Krugmann et al., 1999). FRET data
presented here indicate that NH2 and both COOH termini
of p110  and p101 are in close proximity. The latter finding
is of interest because the p110  COOH terminus harbors
the catalytic domain. Previous data have implied that not
only Ras (Pacold et al., 2000), but also G   (Leopoldt et al.,
1998) directly interact with the COOH terminus of p110 .
Therefore, interaction of p101 with the catalytic domain of
p110  would be in line with the functional data suggesting
that p101 affects interaction of G  -stimulated p110  with
the lipid interface (Maier et al., 1999).
G   is considered to be the principal, direct stimulus of
GPCR-induced PI3K  enzymatic activity. Convincing evi-
dence for this assumption has come from reconstitution of
purified proteins, demonstrating that in vitro, the enzymatic
activity of heterodimeric and monomeric PI3K  is signifi-
cantly stimulated by G   (Stoyanov et al., 1995; Stephens et
al., 1997; Tang and Downes, 1997; Leopoldt et al., 1998).
However, when we challenged the concept in living cells,
marked differences in the sensitivities between heterodimeric
and monomeric PI3K  emerged. The G protein–coupled
fMLP receptor activated p110 /p101, but not p110 , as evi-
dent from the translocation of fluorescent PtdIns-3,4,5-P3
sensors or the stimulation of Akt phosphorylation. Likewise,
coexpressed G   recruited p110 /p101, but not p110 , to
membranes of HEK cells. Interestingly, PI3K , another
G  -regulated PI3K, did not translocate to the membrane
on GPCRs or G   stimulation, whereas RTKs induced
membrane recruitment in vivo (unpublished data).
Does membrane recruitment of PI3K  by itself result in
constitutive activation of p110 ? To answer this intriguing
question, we used an isoprenylated mutant of p110 , i.e.,
p110 -CAAX, which is permanently attached to the mem-
brane, and thereby, is in close proximity to its lipid sub-
strates. Expression of p110 -CAAX only slightly enhanced
membrane association of fluorescent PtdIns-3,4,5-P3 sensors
in HEK or VSM cells. Notably, it did not affect the mor-
phology of HEK cells. In contrast, coexpression of G   to-
gether with p110 -CAAX induced morphological changes
comparable to cells transfected with plasmids encoding G  
and p110 /p101. Furthermore, stimulation of the cells with
fMLP stimulated Akt phosphorylation and membrane re-
cruitment of PH domains regardless of whether p110 /
p101 or p110 -CAAX was the effector. This establishes a
second role for G  , i.e., the activation of the membrane-
attached catalytic p110  subunit even in the absence of p101
(Fig. 9). Although G   interacts with either monomeric
Figure 8. PI3K -mediated membrane translocation of GFP-GRP1PH 
in vascular smooth muscle (VSM) cells. VSM cells were microinjected 
with plasmids for GFP-GRP1PH, fMLP-R, p101, and p110  or p110 -
CAAX in different combinations. The localization of GFP-GRP1PH 
was monitored before and after the addition of 1  M fMLP (picture 
taken after 4 min) and 10 ng/ml PDGF-BB (added 12 min later, picture 
taken after 8 min). White bars indicate a 10- m scale.
Figure 9. Hypothetical model for receptor-
induced membrane recruitment and activation of 
heterodimeric PI3K . fMLP receptor, a prototypical 
heptahelical receptor coupled to Gi proteins. PI3K ; 
the cytosolic enzyme consists of a noncatalytic 
p101 subunit, which is in a tight complex with 
p110 , thereby stabilizing p101. The NH2 and 
COOH termini of p101 and p110  are oriented in 
close proximity, respectively. Contact sites involve 
the NH2 termini of both subunits. The modular 
domain structure of p110  (RBD, Ras binding 
domain; C2, C2 domain; hel, helical domain; 
N-cat, C-cat, NH2- and COOH-terminal lobes of the catalytic domain) is based on the crystal structure of an NH2-terminally truncated p110 . 
(A) Membrane recruitment. The agonist-stimulated receptor induces the release of G   from Gi proteins (dotted arrow). G   recruits the PI3K  
heterodimer to the plasma membrane (dotted arrow) by binding to the noncatalytic p101 (hollow arrow). Accordingly, G   and p101 function 
as a membrane anchor and an adaptor for PI3K , respectively. In addition, the C2 domain of p110  may facilitate membrane attachment 
through interaction with phospholipids. p101 may also affect the interaction of PI3K  with the lipid interface. Membrane-attached PI3K  
exhibits basal enzymatic activity. (B) Allosteric activation. At the membrane, G   activates PI3K  by direct interaction with p110  (hollow 
arrows). This stimulation does not require p101. However, p101 may participate in G  -induced stimulation of membrane-attached p110 . 
The stoichiometry of the G  –PI3K  interaction is unknown, i.e., G   may interact with p101 and p110  through individual or common 
binding sites. G   binds to the NH2- and COOH-terminal part of p110 , the latter harboring the catalytic domain. Thus, G   may allosterically 
activate PI3K  through a conformational change in the catalytic domain. Accordingly, G   significantly increases Vmax of PtdIns-3,4,5-P3 
production. PtdIns-3,4,5-P3, in turn, recruits PH domain–containing effectors such as GRP1 or Btk to the plasma membrane (dotted arrow).T
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PI3K  subunit through individual binding sites, it does not
exclude the possibility that heterodimeric PI3K  forms ei-
ther a common or different binding site(s) for G  . At-
tempts to determine the stoichiometry of the interaction be-
tween heterodimeric PI3K  and one or more G   were
inconclusive. One possible reason may be a weak affinity be-
tween p110  and G  , whereas p101 binds at least with
moderate affinity to G   as determined by copurification
studies (Stephens et al., 1997; Krugmann et al., 1999; Maier
et al., 1999) and by a Biacore plasmon resonance approach
(unpublished data).
In our paper, we present evidence that p110  is stable as a
monomer without p101, but not vice versa. This may explain
why relevant amounts of native monomeric p101 do not oc-
cur in vivo (Wetzker, R., personal communication). p110 
can be expressed as a stable protein independent of the pres-
ence of p101, as shown previously (Fig. 2 C; Lopez-Ilasaca et
al., 1997, 1998; Leopoldt et al., 1998; Maier et al., 1999). In-
terestingly, the p110 subunit of class IA PI3Ks needs stabiliza-
tion by forming a complex with the p85 adaptor (Yu et al.,
1998). Accordingly, class IA p110 , ,  subunits are thought
to occur only in their adaptor-bound form. Moreover, the
p85 adaptor is more abundant than the p110 counterparts
(Ueki et al., 2002). In contrast, p110  is also suggested to oc-
cur in the absence of p101 (Baier et al., 1999).
Increasing evidences suggest that monomeric p110  may
also function as a downstream regulator of GPCR-depen-
dent signal transduction pathways in cells (Lopez-Ilasaca et
al., 1997, 1998; Bondeva et al., 1998; Murga et al., 1998;
Baier et al., 1999). However, under in vivo conditions the
p101 subunit seems mandatory for G protein–mediated ac-
tivation of PI3K  by mediating membrane recruitment.
Therefore, the question arises of how monomeric p110 
translocates to the membrane. In this context, recent in vitro
evidence points to the possibility that membrane attachment
of p110  may involve binding to anionic phospholipids
(Kirsch et al., 2001). In line with this finding, the majority
of PI3K  is already associated with lipid vesicles in the ab-
sence of G   under in vitro conditions, and vesicle-bound
PI3K  can still be activated by G   (Krugmann et al.,
2002). Alternatively, p110  may be recruited by binding to
membrane-anchored proteins other than G  . In this re-
spect, p110 , like all other class I PI3Ks, is directly activated
by GTP-bound Ras (Pacold et al., 2000).
In conclusion, we present in vivo evidence that G   may
stimulate PI3K  in a dual and complementary way, i.e., by
recruitment to the membrane, and by activation of the
membrane-bound enzyme (Fig. 9). In this scenario, the
p101 subunit functions as an adaptor molecule necessary to
recruit the catalytic subunit to the plasma membrane
through high affinity interaction with G  . In turn, direct
interaction between G   and the membrane-attached cata-
lytic p110  subunit contributes to a final activation of the
enzyme by a mechanism other than translocation.
Materials and methods
Construction of expression plasmids
For generation of expression plasmids of PI3K  subunits, restriction sites
were introduced, and stop codons were removed by 8–12 cycles of PCR
using the indicated primers, a PCR system (Expand HF; Roche), and a
pcDNA3.1/V5-His-TOPO vector (Invitrogen) for first subcloning. Sub-
cloned PCR fragments were confirmed by sequencing with fluorescent dye
terminators (ABI-Prism 377; PerkinElmer). Expression plasmids encoding
NH2- and COOH-terminally tagged fusion proteins were generated by sub-
sequent subcloning into the vectors pEYFP-C1 and pECFP-C1 (CLONTECH
Laboratories, Inc.) or into pcDNA3-YFP and pcDNA3-CFP (Schaefer et al.,
2001), respectively. The constructs are designated indicating the color and
the position of the tag (see Fig. 1 A). In detail, wild-type p110 ; human
p110  cDNA (Stoyanov et al., 1995; a corrected nucleotide sequence for
p110  is available from GenBank/EMBL/DDBJ, accession no. AF327656)
was amplified with the primers 5 -GCC ACC ATG GAG CTG GAG AAC
TAT AA-3  and 5 -GGA TCC AGC TTT CAC AAT GTC TAT TG-3 , and
subcloned into pcDNA3 via KpnI and XhoI. p110 -YFP and -CFP; the stop
codon was replaced by an XbaI site using the primer 5 -GTC TAG AGC
TGA ATG TTT CTC TCC CTT GT-3  and the same forward primer as
above. Subcloning into pcDNA3-YFP and -CFP was done via BamHI and
XbaI. YFP- and CFP-p110 ; XhoI and BamHI sites were introduced using
the primers 5 -CTC GAG GCA TGG AGC TGG AGA ACT A-3  and 5 -
GGA TCC AGC TTT CAC AAT GTC TAT TG-3  for subcloning into pEYFP-
C1 and pECFP-C1. p110 -K833R; position 2498 was mutated from A to G
using the QuikChange
® Mutagenesis Kit (Stratagene) and appropriate prim-
ers. p110 -CAAX; two AfeI sites in p110  were removed, and the stop
codon was replaced by a new AfeI site by silent mutations using the
QuikChange
® Mutagenesis Kit and appropriate primers. Adaptor oligonu-
cleotides encoding the 18 COOH-terminal amino acids of H-Ras were in-
serted into the AfeI and BamHI sites. Wild-type p101; the cDNA for por-
cine p101 (Stephens et al., 1997) was subcloned in pcDNA3 via EcoRI and
NotI. An optimized ribosomal docking sequence was introduced by PCR
using the primers 5 -GCC ACC ATG CAG CCA GGG GCC ACG GA-3 
and 5 -GGC CCG AGA CGA AGG AGG T-3  and subsequent exchange of
the 5 -end via HindIII and BsmBI. YFP- and CFP-p101; the EcoRI/NotI frag-
ment of p101 was subcloned into EcoRI/Bsp120I-digested pEYFP-C1 or
pECFP-C1. To adapt the reading frames, the HindIII site was blunted with
Klenow fragment (New England Biolabs, Inc.) and religated. p101-YFP and
-CFP; PCR with the primers 5 -GTC CTC TCC TCA CAC GGT TCT T-3 
and 5 -GTC TAG AGG CAG AGC TCC GCT GAA AGT-3  generated the
3 -end of p101 with an XbaI site instead of the stop codon. To restore
the full-length p101 cDNA, the 5 -part was excised from wild-type
p101 in pcDNA3 with HindIII and ClaI (partial digest) and ligated to the
HindIII/ClaI-digested 3 -end. Subsequent subcloning in pcDNA3-YFP and
pcDNA3-CFP was done via HindIII and XbaI.
The human fMLP receptor cDNA (Boulay et al., 1990) was amplified
with the primers 5 -GCC ACC ATG GAG ACA AAT TCC TCT CTC-3  and
5 -TCA CTT TGC CTG TAA CTC CAC-3  and subcloned in pcDNA3 via
HindIII and XhoI. The cDNAs of G i2 (Conklin et al., 1993), human G 1
(Codina et al., 1986), and bovine G 2 (Gautam et al., 1989) were sub-
cloned into pcDNA3. Plasmids for GFP-GRP1PH and Ras N17 are de-
scribed elsewhere (Ridley et al., 1992; Gray et al., 1999).
For generation of expression plasmids encoding CFP-tagged G 1 and
BtkPH, restriction sites were introduced by PCR using the indicated primers,
the Advantage™ II PCR enzyme system (CLONTECH Laboratories, Inc.)
and the pGEM
®-T Easy Vector (Promega) for first subcloning. The G 1
cDNA was amplified using the primers 5 -TAC AAG TCC GGA CAA GCT
TCC ATG AGT GAG CTT GAC CAG TTA CGG C-3  and 5 -CGG GAT
CCG TCG ACC CAT GGT GGC GTT AGT TCC AGA TCT TGA GGA AGC-
3 , allowing for in-frame subcloning into the HindIII and BamHI sites of
pECFP-C1. The cDNA encoding the PH domain of human Btk (Várnai et
al., 1999) and adjacent 5  untranslated bases was amplified from cDNA of
dibuturyl-cAMP–differentiated HL-60 cells using the primers 5 -CCA AGT
CCT GGC ATC TCA ATG CAT CTG-3  and 5 -TGG AGA CTG GTG CTG
CTG CTG GCT C-3 . A nested PCR was performed using the primers 5 -
GGA AGA TCT CGA GCC ACC ATG GCC GCA GTG ATT CTG G-3  and
5 -GGG GAT CCC GGG CCC GAG GTT TTA AGC TTC CAT TCC TGT
TCT CC-3 , allowing for in-frame subcloning into the XhoI and BamHI
sites of pECFP-N1 (CLONTECH Laboratories, Inc.). The cDNA inserts and
flanking regions of the resulting CFP-G 1 and BtkPH-CFP constructs were
confirmed by sequencing.
Cell culture, transfection, and intranuclear microinjection
HEK 293 cells (American Type Culture Collection) were grown at 37 C
with 5% CO2 in DME or in MEM with Earle’s salts supplemented with 10%
FCS, 100  g/ml streptomycin, and 100 U/ml penicillin. All transfections
were done with a FuGENE™ 6 transfection reagent (Roche) following the
manufacturer’s recommendations. For fluorescence microscopy experi-
ments, cells were seeded on glass coverslips. For confocal imaging of theT
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subcellular localization of the PI3K  subunits, cells were transfected with
0.1  g of plasmid encoding YFP-tagged PI3K  subunits, 0.2  g of plasmid
for the untagged complementary subunit, and 1  g each of plasmid for
G 1 and G 2 (except for the experiment shown in Fig. 4 B; 0.1  g YFP-
p101   2  g G 1 or G 2 alone, or 0.5  g G 1   0.5  g G 2   1  g G i2).
For monitoring PH domain translocation, or Akt- or ERK phosphorylation,
HEK cells were transfected with 0.2  g plasmid encoding the fMLP recep-
tor, and 0.4  g each of the plasmids encoding the PI3K  subunits and the
fluorescent PH domain. The total amount of transfected cDNA was always
kept constant (2.5  g/well) by the addition of empty expression vector. For
FRET analysis, cells were transfected with 1.5  g of plasmid encoding the
YFP-tagged p110  and 0.5  g of plasmid for CFP-tagged p101. All experi-
ments were performed one or two days after transfection.
VSM cells from neonatal rat aortas were cultured as described previ-
ously (Reusch et al., 2001). Cells were seeded on glass coverslips and mi-
croinjected with the plasmids for GFP-GRP1PH (0.4  g/ml), fMLP receptor
(0.05  g/ml), p110  (0.05  g/ml), and p101 (0.05  g/ml) using an Eppen-
dorf micromanipulator and transjector. Confocal images were taken one
day after microinjection.
Immunoblot analysis of whole-cell lysates, gel filtration, 
and membrane fractions
p110 /p101 titration; transfected HEK cells were lysed in Laemmli buffer
and whole-cell lysates including nuclei were subjected to a 10% SDS-
PAGE. Proteins were blotted on nitrocellulose membranes, probed with
anti-GFP (CLONTECH Laboratories, Inc.) and peroxidase-coupled anti–rab-
bit IgG antibodies (Sigma-Aldrich) and visualized by ECL (Amersham Bio-
sciences). Akt and ERK phosphorylation; HEK 293 cells were transfected as
indicated with the plasmids encoding the fMLP receptor (0.2  g), PI3K 
subunits (each 0.4  g), and H-Ras N17 (1.5  g). Cells were serum-starved
overnight, then stimulated as indicated, and lysed in Laemmli buffer.
Whole-cell lysates were subjected to SDS-PAGE and immunoblotting, and
probed with anti–Phospho-Akt or anti–Phospho-ERK1/2 and anti-ERK1/2
as described previously (Reusch et al., 2001). Gel filtration; HEK cells were
transfected with equal amounts of the plasmids for YFP-p110  (or p110 -
YFP) and CFP-p101 (or pcDNA3). Cells were washed in PBS and lysed in
20 mM Hepes, pH 7.5, 150 mM NaCl, 10 mM  -mercaptoethanol, 4 mM
EDTA, 0.2% polyoxyethylene-10-laurylether (C12E10), 200  M Pefabloc
®
SC, 30  g/ml TPCK, 30  g/ml trypsin inhibitor, and 50  g/ml benzamidine
by repetitive aspiration through a 26-gauge needle. Cytosols were pre-
pared (100,000 g for 30 min at 4 C), and subjected to gel filtration on a 24-
ml Superdex 200 column and eluted with the same buffer on an ÄKTA™
purifier system (Amersham Biosciences). Fractions were collected, and ali-
quots were subjected to SDS-PAGE and immunoblotting with anti-GFP.
Preparation of membrane fractions; HEK cells were transfected as indi-
cated with the plasmids for YFP-p110 -K833R (0.1  g), p101 (0.2  g), G 1
(1.0  g), and G 2 (1.0  g). Cells were washed with PBS and lysed in PBS
with protease inhibitors (see above) by repetitive aspiration through a 26-
gauge needle. Membranes were prepared (16,000 g for 20 min at 4 C), re-
dissolved in Laemmli buffer, subjected to SDS-PAGE and immunoblotting,
and probed with anti-p110  (see next section) and anti-G common (AS398;
Leopoldt et al., 1997).
In vitro PI3K assay
HEK cells were transfected with equal amounts of the plasmids encoding
p110  and p101 (or empty pcDNA3 to keep the total amount of trans-
fected cDNA constant). Cell lysates were subjected to immunoprecipita-
tion using a monoclonal anti-p110  antibody (Bondev et al., 2001). In
brief, protein A Sepharose was preincubated with or without antibody,
washed, incubated overnight with cleared lysates, and washed again. The
in vitro PI3K assay was performed as described previously (Maier et al.,
1999). Radioactive PtdIns-3,4,5-P3 was visualized with a PhosphorImager
(Fuji Bas-Reader 1500; Ray Test).
Fluorescence imaging and detection of FRET
Glass coverslips were mounted on a custom-made chamber and covered
with a Hepes-buffered solution containing 138 mM NaCl, 6 mM KCl, 1
mM MgCl2, 1 mM CaCl2, 5.5 mM glucose, 10 mM Hepes, pH 7.5, and 2
mg/ml BSA. For confocal imaging, an inverted confocal laser scanning mi-
croscope with a Plan-Apochromat 63 /1.4 objective (model LSM 510;
Carl Zeiss MicroImaging, Inc.) was used. YFP or GFP were excited at 488
nm, and fluorescence emission was detected through a 505-nm long pass
filter. CFP was excited 458 nm, and detected through a 475-nm long pass
filter. Pinholes were adjusted to yield optical sections of 0.5–1.5  m.
FRET analysis was performed using an inverted microscope with a Plan-
Apochromat 63 /1.4 objective (Axiovert 100; Carl Zeiss MicroImaging,
Inc.). CFP and YFP were alternately excited at 440 and 500 nm with a
monochromator (Polychrome II; TILL Photonics) in combination with a
dual reflectivity dichroic mirror ( 460 nm and 500–520 nm; Chroma
Technology Corp.). Emitted light was filtered through 475–505-nm (CFP)
and 535–565-nm (YFP) band pass filters, changed by a motorized filter
wheel (Lambda 10/2; Sutter Instrument Co.), and detected by a cooled
CCD camera (Imago; TILL Photonics). FRET was assessed as recovery of
CFP (donor) fluorescence during YFP (acceptor) bleach. First, CFP and YFP
fluorescences without acceptor bleach were recorded during 30 cycles
with a 10–20-ms exposure. Then, 60 cycles were recorded with an addi-
tional 2-s illumination per cycle at 510 nm to bleach YFP.
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